Joincare extends ¥580m in guarantees to four subsidiaries

Joincare Pharmaceutical Group Industry Co., Ltd. has entered into guarantee agreements with Ping An Bank for its four wholly-owned subsidiaries, totaling ¥580,000,000. These guarantees are provided to Shenzhen Haibin Pharmaceutical Co., Ltd. (¥200,000,000), Shenzhen Taizaitai Pharmaceutical Co., Ltd. (¥80,000,000), Jiaozuo Joincare Bio-Product Co., Ltd. (¥200,000,000), and Joincare Haibin Pharmaceutical Co., Ltd. (¥100,000,000). The guarantees are for a period of three years from the debt maturity date of each single credit business's principal contract.

As of August 31, 2025, the company's total outstanding guarantee balance amounted to ¥283,439,920. Of this, guarantees for subsidiaries with an asset-liability ratio exceeding 70% totaled ¥136,634,740, while guarantees for those below 70% and associated companies totaled ¥146,815,180. These figures represent 19.50% of the company's net assets attributable to shareholders as of the latest audited period (¥14,534,719,600). The company has no overdue external guarantees.

The board of directors approved these guarantees on April 7, 2025, to meet the daily operational and business development needs of its subsidiaries. The company affirms it is in good operational standing with no significant defaults, litigation, or arbitration matters that would impair its ability to repay debt, ensuring overall controllable guarantee risk.